Published in Cancer Res on January 15, 2001
Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer (2013) 4.46
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol (2003) 1.44
The p38 MAPK stress pathway as a tumor suppressor or more? Front Biosci (2008) 1.31
The transcriptional response to Raf activation is almost completely dependent on Mitogen-activated Protein Kinase Kinase activity and shows a major autocrine component. Mol Biol Cell (2004) 1.16
A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Mol Cell Biol (2003) 1.03
Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis. Cell Commun Signal (2015) 0.87
Cyclooxygenase in biology and disease. FASEB J (1998) 7.17
Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science (1998) 4.41
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet (1999) 4.22
Palindromic sequences in heteroduplex DNA inhibit mismatch repair in yeast. Nature (1989) 3.45
Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol (1995) 3.31
Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev (1999) 3.19
Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science (1996) 3.18
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol (2001) 3.07
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol (2000) 3.05
Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol (1983) 3.04
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum (2004) 3.00
Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol (1991) 2.69
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol (1996) 2.69
Analysis of a gene conversion gradient at the HIS4 locus in Saccharomyces cerevisiae. Genetics (1992) 2.60
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis. Med J Aust (2000) 2.56
Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest (1997) 2.44
Macrophage-lymphocyte interaction. II. Antigen-mediated physical interactions between immune guinea pig lymph node lymphocytes and syngeneic macrophages. J Exp Med (1975) 2.44
Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells. J Immunol (1979) 2.36
Isolation and characterization of human peripheral blood dendritic cells. J Immunol (1993) 2.33
The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells. Immunol Today (1989) 2.31
Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol (1985) 2.27
The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum (1994) 2.26
A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol (1998) 2.20
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol (2000) 2.17
Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3. J Immunol (1987) 2.03
Macrophage-lymphocyte interaction. I. Characteristics of the antigen-independent-binding of guinea pig thymocytes and lymphocytes to syngeneic macrophages. J Exp Med (1973) 2.00
Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. J Immunol (1987) 1.97
Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay. J Immunol (1978) 1.93
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum (1988) 1.90
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Efficacy of an internet-based behavioral weight loss program for overweight adolescent African-American girls. Eat Weight Disord (2005) 1.88
Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation. J Biol Chem (1998) 1.86
Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (1996) 1.85
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Genetic evidence that the meiotic recombination hotspot at the HIS4 locus of Saccharomyces cerevisiae does not represent a site for a symmetrically processed double-strand break. Genetics (1993) 1.85
Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol (1990) 1.83
Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol (1997) 1.80
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum (1998) 1.79
The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol (1985) 1.78
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol (1988) 1.71
Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J Exp Med (1989) 1.69
Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol (1994) 1.67
Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol (1988) 1.67
Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol (1987) 1.66
Spontaneous and induced membrane hyperpolarizations in macrophages. J Cell Physiol (1975) 1.64
Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1985) 1.63
Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J Biol Chem (1999) 1.63
Migration of naive and memory T cells. Immunol Today (1997) 1.62
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum (1990) 1.61
Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest (1996) 1.57
Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci U S A (1990) 1.56
Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest (1997) 1.52
Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell. J Immunol (1990) 1.51
Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest (1998) 1.50
Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis (2005) 1.49
The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. J Immunol (1983) 1.49
Inhibitory influence of IL-4 on human B cell responsiveness. J Immunol (1988) 1.48
Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J Biol Chem (1993) 1.48
Infliximab in active early rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol (1986) 1.46
The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol (1995) 1.46
Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J Clin Invest (1998) 1.45
Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence. J Immunol (1976) 1.45
Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells. J Immunol (1985) 1.44
Macrophage-lymphocyte interaction and antigen recognition. Fed Proc (1975) 1.44
Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus (2004) 1.43
Relationship between clinical efficacy and laboratory correlates of inflammatory and immunologic activity in rheumatoid arthritis patients treated with nonsteroidal antiinflammatory drugs. Arthritis Rheum (1990) 1.43
Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol (1994) 1.43
Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum (1995) 1.42
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev (2000) 1.42
Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. J Biol Chem (1996) 1.42
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum (1994) 1.41
T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol (1988) 1.41
The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am (2000) 1.39
A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol (2001) 1.39
A sensitive and versatile chromogenic assay for peroxidase and peroxidase-coupled reactions. Anal Biochem (1980) 1.38
Accessory cell signals involved in T-cell activation. Immunol Rev (1990) 1.37
Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv Immunol (1987) 1.35
Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur J Immunol (1998) 1.35
Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol (2000) 1.35
Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. J Immunol (1991) 1.34
Cimetidine-associated exacerbation of cutaneous lupus erythematosus. Arch Intern Med (1982) 1.34
Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.33
Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest (1997) 1.32
Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. Mol Cell Biol (2000) 1.31
Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest (1981) 1.31
Spectrophotometric assay for lysine decarboxylase. Anal Biochem (1982) 1.31
ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J Biol Chem (2000) 1.30
Competition between adjacent meiotic recombination hotspots in the yeast Saccharomyces cerevisiae. Genetics (1997) 1.29
Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts. J Immunol (1987) 1.29
Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol (1990) 1.28
Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J Immunol (1991) 1.28
Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes. J Immunol (1986) 1.27
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol (1995) 1.27
Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes. J Immunol (1977) 1.25
The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum (1992) 1.25